Encorium Group Inc. is a full-service multinational contract research organization (CRO). They provide design, development, and management capabilities for clinical trials and patient registries. They do this for many of the world’s leading pharmaceutical companies. Trading on the NASDAQ Capital Market, Encorium Group Inc. has offices in 10 countries, managing clinical trials with their own employees. The Company’s corporate headquarters are in Wayne, Pennsylvania.

Encorium Group, Inc. provides their services to the pharmaceutical, biotechnology, and medical device industries. Their corporate mission is to provide their clients with high quality, full-service support for their biopharmaceutical and medical device development programs. They offer therapeutic expertise, experienced team management, and advanced technologies.

Encorium has drug and biologics development as well as clinical trial experience across a broad spectrum of therapeutic areas. These include infectious diseases, cardiovascular, vaccines, oncology, and diabetes endocrinology/metabolism. These also include gene therapy, immunology, neurology, gastroenterology, dermatology, hepatology, women’s health